Measurement of NAD levels in individuals with and without Alzheimer's Disease using 1H-MRS

fd

About this Study

The study will detect changes in brain levels of the molecule NAD in Alzheimer's disease for future use as a biomarker supporting therapeutic development.

Participation Eligibility:

We are recruiting 10 healthy volunteers and 10 Alzheimer's patients between age 65 and 80. Volunteers will dedicate two mornings, 8 months apart, to the study.

You Cannot Participate if:

  • You are under 65 or over 80 years old.
  • You believe you can't rest quietly in an MRI machine.
  • You have certain types of pacemakers or other electronic devices.
  • You work at night.
  • You have cancer or were diagnosed with cancer within the last 5 years.

Benefits of Participation:

  • We will provide a $50 gift card to defray transportation costs.
  • You will help researchers accelerate the development of treatments to slow or stop the progression of Alzheimer's.

Get Started:

Email:   crudor@health.fau.edu

Where?

FAU Clinical Trials Unit

777 Glades Road, ME-104 Bldg 1

Boca Raton, FL 33431

FAU Research

Florida Atlantic is an R1 research institution where scientists and students collaborate toward common goals of improving human health, protecting our oceans and creating smarter spaces through artificial intelligence. Learn more about our four institutes, our accomplishments and our latest discoveries.

Connect with Florida Atlantic Research